These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23830149)

  • 21. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
    Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
    J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual arousal and lubrication problems in women with clinically diagnosed hypoactive sexual desire disorder: preliminary findings from the hypoactive sexual desire disorder registry for women.
    Maserejian NN; Shifren J; Parish SJ; Segraves RT; Huang L; Rosen RC
    J Sex Marital Ther; 2012; 38(1):41-62. PubMed ID: 22268981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.
    Dennerstein L; Koochaki P; Barton I; Graziottin A
    J Sex Med; 2006 Mar; 3(2):212-22. PubMed ID: 16490014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of cerebrocortical areas associated with sexual arousal in depressive women using functional MR imaging.
    Yang JC; Park K; Eun SJ; Lee MS; Yoon JS; Shin IS; Kim YK; Chung TW; Kang HK; Jeong GW
    J Sex Med; 2008 Mar; 5(3):602-9. PubMed ID: 18194182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoactive Sexual Desire Disorder: A Review of Epidemiology, Biopsychology, Diagnosis, and Treatment.
    Parish SJ; Hahn SR
    Sex Med Rev; 2016 Apr; 4(2):103-120. PubMed ID: 27872021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
    Simon JA; Thorp J; Millheiser L
    J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
    Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
    Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences between pre- and postmenopausal women in cues for sexual desire.
    McCall K; Meston C
    J Sex Med; 2007 Mar; 4(2):364-71. PubMed ID: 17367431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The characteristics of hypoactive sexual desire disorder in Korean women who visited a community-based gynaecology hospital for sexual dysfunction.
    Yun HJ; Cho HH
    J Obstet Gynaecol; 2018 Jul; 38(5):663-667. PubMed ID: 29433404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
    Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
    J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase Inhibitors Are Associated With Low Sexual Desire Causing Distress and Fecal Incontinence in Women: An Observational Study.
    Robinson PJ; Bell RJ; Christakis MK; Ivezic SR; Davis SR
    J Sex Med; 2017 Dec; 14(12):1566-1574. PubMed ID: 29066307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.
    Sills T; Wunderlich G; Pyke R; Segraves RT; Leiblum S; Clayton A; Cotton D; Evans K
    J Sex Med; 2005 Nov; 2(6):801-18. PubMed ID: 16422805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
    Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
    J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depression in premenopausal women with HSDD: baseline findings from the HSDD Registry for Women.
    Clayton AH; Maserejian NN; Connor MK; Huang L; Heiman JR; Rosen RC
    Psychosom Med; 2012 Apr; 74(3):305-11. PubMed ID: 22434918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
    Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
    J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.
    Thurston L; Hunjan T; Ertl N; Wall MB; Mills EG; Suladze S; Patel B; Alexander EC; Muzi B; Bassett PA; Rabiner EA; Bech P; Goldmeier D; Abbara A; Comninos AN; Dhillo WS
    JAMA Netw Open; 2022 Oct; 5(10):e2236131. PubMed ID: 36287566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women.
    West SL; D'Aloisio AA; Agans RP; Kalsbeek WD; Borisov NN; Thorp JM
    Arch Intern Med; 2008 Jul; 168(13):1441-9. PubMed ID: 18625925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
    Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
    J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivity.
    Clayton AH; DeRogatis LR; Rosen RC; Pyke R
    J Sex Med; 2012 Aug; 9(8):2027-39. PubMed ID: 22788382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The HSDD registry for women: a novel patient registry for women with generalized acquired hypoactive sexual desire disorder.
    Rosen RC; Connor MK; Maserejian NN
    J Sex Med; 2010 May; 7(5):1747-56. PubMed ID: 20233298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.